Xu-Fei Huang

4PUBLICATIONS
1CO-AUTHORS
Respiratory diseasesNanomedicineMolecular medicineMedical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 01, 2019
What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?

Hao Zhao, Xu-Fei Huang, Xue-Min Gao

|Apr 06, 2018
Prognostic value of serum vascular endothelial growth factor and hematological responses in patients with newly-diagnosed POEMS syndrome.

Hao Zhao, Hao Cai, Chen Wang

|Apr 01, 2018
A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome.

Jian Li, Xu-Fei Huang, Qian-Qian Cai

|Nov 12, 2016
Measurement of β-isomerized C-terminal telopeptide of type I collagen in patients with POEMS syndrome: diagnostic, prognostic, and follow-up utilities.

X Huang, C Zhang, C Wang

Pageof 1

Frequent Collaborators

1 joint publications

Jian Li